Femoral Varus Derotation Osteotomy for the Treatment of Habitual Subluxation and Dislocation of the Pediatric Hip in Trisomy 21: A 10-Year Experience

被引:20
|
作者
Knight, Dominique M. A. [1 ]
Alves, Cristina [1 ]
Wedge, John H. [1 ]
机构
[1] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada
关键词
trisomy; 21; hip dislocation; hip subluxation; surgical treatment; varus femoral derotation osteotomy; DOWN-SYNDROME; ORTHOPEDIC DISORDERS; ABNORMALITIES; DISEASE; JOINT;
D O I
10.1097/BPO.0b013e3182285fa5
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Habitual hip subluxation and dislocation are potentially disabling features of the trisomy 21 syndrome. We describe outcomes after a femoral varus derotation osteotomy to achieve and maintain hip stability and community ambulation. Methods: All individuals with trisomy 21, who underwent hip surgery at our institution between 1998 and 2008, were searched using the hospital databases. The clinical notes and radiographs were reviewed from presentation to final follow-up. Nine children (16 hips) aged below 10 years, were identified. All had a femoral varus derotation osteotomy with a target femoral neck-shaft angle (NSA) of 105 degrees and external rotation of < 20 degrees of the distal fragment. All were performed by the senior author. Results: Mean age at first known hip dislocation was 4.6 years (range, 4 to 5.2 y), mean age at surgery was 6.1 years (range, 5.2 to 7.0 y), and mean follow-up was 5.4 years (range, 3.8 to 7.1 y). Mean NSA fell postoperatively to 106.0 degrees (range, 103.1 to 110.2 degrees) from 166.7 degrees (range, 162.2 to 171.1 degrees). In 2 hips, intraoperative instability remained, requiring immediate periacetabular osteotomy and capsulorraphy. Post-operatively, all patients demonstrated an asymptomatic waddling gait, which persisted in 1 individual. Fourteen hips developed peritrochanteric varus deformities with a mean center of rotation and angulation of 21 degrees (range, 16 to 25 degrees). Two hips (12.5%) sustained implant-related fractures 4 and 8 years postoperatively. One hip (6.3%) developed arthritis and none had redislocated at latest follow-up. Conclusions: Sequelae from recurrent subluxation or dislocation of hips in trisomy 21 may require surgery to prevent eventual disability. We recommend a varus producing proximal femoral osteotomy correcting the NSA to approximately 105 degrees. This should be performed before the age of 7 years or a widened or V-shape teardrop develops. After 2 implant-related fractures, we recommend implant removal once the osteotomy has healed and the hip stabilized. In our experience, this approach is effective in maintaining hip stability. Level of Evidence: A level 4 study, looking at a specific patient population undergoing a particular procedure.
引用
收藏
页码:638 / 643
页数:6
相关论文
共 29 条
  • [21] DIAGNOSIS AND TREATMENT OF ADRENAL MASSES IN CHILDREN: 10-YEAR EXPERIENCE AT A HIGH-COMPLEXITY PEDIATRIC HOSPITAL
    Gonzalez Villarreal, Laura
    Castrillon Herrera, Adriana
    Plazas Hernandez, Diana
    Olaya Morales, Natalia
    Patino Calderon, Esteban
    Valero Halaby, Juan
    Molina Ramirez, Ivan
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S167 - S167
  • [22] Second Place Award: Residents or hip surgeons for the treatment of displaced femoral neck fractures? A 10-year survivorship rate analysis
    Diaz Dilernia, Fernando
    Garcia Mansilla, Agustin
    Llano, Lionel
    Buljubasich, Martin
    Ignacio Onativia, Jose
    Alejandro Buttaro, Martin
    CURRENT ORTHOPAEDIC PRACTICE, 2019, 30 (04): : 296 - 303
  • [23] A 10-Year Experience of an Integrated Geriatric Hip Fracture Treatment Protocol: Outcomes at a Minimum 2-Year Follow-Up
    Hayward-Livingston, Anna
    Ozdag, Yagiz
    Kolessar, David
    Weinberg, Jacob
    Pamul, Arpitha
    Koury, Kenneth
    Balsamo, Anthony
    GERIATRIC ORTHOPAEDIC SURGERY & REHABILITATION, 2024, 15
  • [24] Cemented total hip arthroplasty with subtrochanteric femoral shortening transverse osteotomy for severely dislocated hips: outcome with a 3-to 10-year follow-up period
    Akiyama, Haruhiko
    Kawanabe, Keiichi
    Yamamoto, Koji
    Kuroda, Yutaka
    So, Kazutaka
    Goto, Koji
    Nakamura, Takashi
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2011, 16 (03) : 270 - 277
  • [25] Clinical profile, treatment and outcome of pediatric brain tumors in Serbia in a 10-year period: A national referral institution experience
    Stanic, Dragana
    Grujicic, Danica
    Pekmezovic, Tatjana
    Bokun, Jelena
    Popovic-Vukovic, Marija
    Janic, Dragana
    Paripovic, Lejla
    Ilic, Vesna
    Slovic, Marija Pudrlja
    Ilic, Rosanda
    Raicevic, Savo
    Saric, Milan
    Miskovic, Ivana
    Nidzovic, Borko
    Nikitovic, Marina
    PLOS ONE, 2021, 16 (10):
  • [26] Treatment of Crowe Type-IV Hip Dysplasia Using Cementless Total Hip Arthroplasty and Double Chevron Subtrochanteric Shortening Osteotomy: A 5-to 10-Year Follow-Up Study
    Li, Xigong
    Lu, Yang
    Sun, Junying
    Lin, Xiangjin
    Tang, Tiansi
    JOURNAL OF ARTHROPLASTY, 2017, 32 (02): : 475 - 479
  • [27] Long-term hip survival and factors influencing patient-reported outcomes after transtrochanteric anterior rotational osteotomy for osteonecrosis of the femoral head: A minimum 10-year follow-up case series
    Kawano, Koichiro
    Motomura, Goro
    Ikemura, Satoshi
    Kubo, Yusuke
    Fukushi, Junichi
    Hamai, Satoshi
    Fujii, Masanori
    Nakashima, Yasuharu
    MODERN RHEUMATOLOGY, 2020, 30 (01) : 184 - 190
  • [28] Long-term survival after cemented versus uncemented total hip arthroplasty for treatment of acute femoral neck fracture: a retrospective study with a mean 10-year follow-up
    Zhang, Chi
    Chen, Meiji
    Yu, Weiguang
    Han, Xiulan
    Ye, Junxing
    Zhuang, Jintao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (09)
  • [29] TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 2ND REMISSION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AND CHEMOTHERAPY - 10-YEAR EXPERIENCE OF THE ITALIAN BONE-MARROW TRANSPLANTATION GROUP AND THE ITALIAN-PEDIATRIC-HEMATOLOGY-ONCOLOGY-ASSOCIATION
    UDERZO, C
    VALSECCHI, MG
    BACIGALUPO, A
    MELONI, G
    MESSINA, C
    POLCHI, P
    DIGIROLAMO, G
    DINI, G
    MINIERO, R
    LOCATELLI, F
    COLELLA, R
    TAMARO, P
    LOCURTO, M
    DITULLIO, MT
    MASERA, G
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) : 352 - 358